{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:21:56Z","timestamp":1787008916727,"version":"build-2736575974"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"General Projects of Social Development in Shaanxi Province","award":["2022SF-565"],"award-info":[{"award-number":["2022SF-565"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>Does an increased dosing of FSH improve the live birth rate as compared to standard FSH dosing in expected poor responders who undergo IVF?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>In this trial, women with an expected poor response allocated to increased FSH dosing did not have a statistically significant increase in cumulative live births as compared to a standard FSH dose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>Poor ovarian reserve leads to worse IVF outcomes owing to the low number and quality of oocytes. Clinicians often individualize the FSH dose using ovarian reserve tests, including antral follicle count (AFC), and basal plasma FSH or anti-M\u00fcllerian hormone level. However, the evidence that increased FSH dosing improves fertility outcomes in women with an expected poor response is lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>We performed a parallel, open-label randomized controlled trial between March 2019 and October 2021 in an assisted reproduction centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>Women &amp;lt;43\u2009years of age with AFC &amp;lt;10 referred for their first IVF cycle were randomized for increased or standard FSH dosing. In participants allocated to increased FSH dosing, women with AFC 1\u20136 started with 300\u2009IU\/day, while women with AFC 7\u20139 started with 225\u2009IU\/day. In participants allocated to the standard care, women started with 150\u2009IU\/day. The primary outcome was cumulative live birth attributable to the first IVF cycle including fresh and subsequent frozen-thawed cycles within 18\u2009months of randomization. Live birth was defined as the delivery of one or more living infants \u226524 weeks\u2019 gestation. This trial was powered to detect an 11% difference in live birth attributable to the first IVF cycle. Outcomes were evaluated from an intention-to-treat perspective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>We randomized 661 women to start FSH at increased dosing (n\u2009=\u2009328) or standard dosing (n\u2009=\u2009333). The primary outcome cumulative live birth occurred in 162\/328 (49.4%) women in the increased group versus 141\/333 (42.3%) women in the standard group [risk ratio (RR) 1.17 (95% CI, 0.99\u20131.38), risk difference 0.07 (95% CI, \u22120.005, 0.15), P\u2009=\u20090.070]. The live birth rate after the first embryo transfer in the increased versus standard group was 125\/328 (38.1%) versus 117\/333 (35.1%), respectively [RR 1.08 (95% CI, 0.83\u20131.33), P\u2009=\u20090.428]. Cumulative clinical pregnancy rates were 59.1% versus 57.1% [RR 1.04 (95% CI, 0.91\u20131.18), P\u2009=\u20090.586] with miscarriage rates of 9.8% versus 14.4% [RR 0.68 (95% CI, 0.44\u20131.03), P\u2009=\u20090.069] in the increased versus standard group, respectively. Other secondary outcomes, including biochemical pregnancy, ongoing pregnancy, multiple pregnancy and ectopic pregnancy, were not significantly different between the two groups both from the first and cumulative embryo transfer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>As this study is open-label, potential selective cancelling and small dose adjustments could have influenced the results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>In women with predicted poor response, we did not find evidence that increased FSH dosing improves live birth rates. A standard dose of 150\u2009IU\/day is recommended at the start of IVF in these women to reduce potential adverse effects and costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                    <jats:p>This study was funded by the General Projects of Social Development in Shaanxi Province (No. 2022SF-565). B.W.M. is supported by NHMRC (GNT1176437). B.W.M. reports personal fees from ObsEva, and funding from Merck and Ferring outside the submitted work.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>Registered at Chinese clinical trial registry (www.chictr.org.cn). Registration number ChiCTR1900021944.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION DATE<\/jats:title>\n                    <jats:p>17 March 2019<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATE OF FIRST PATIENT\u2019S ENROLMENT<\/jats:title>\n                    <jats:p>20 March 2019<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humrep\/deac113","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T07:35:57Z","timestamp":1651822557000},"page":"1806-1815","source":"Crossref","is-referenced-by-count":32,"title":["Increased versus standard gonadotrophin dosing in predicted poor responders of IVF: an open-label randomized controlled trial"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9016-4946","authenticated-orcid":false,"given":"Xitong","family":"Liu","sequence":"first","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi'an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wen","sequence":"additional","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi'an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi'an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tian","sequence":"additional","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi'an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi'an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi'an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi'an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4211-8563","authenticated-orcid":false,"given":"Hanying","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi'an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi'an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2644-5812","authenticated-orcid":false,"given":"Pengfei","family":"Qu","sequence":"additional","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi'an, Shaanxi Province, China"},{"name":"Translational Medicine Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi'an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8337-550X","authenticated-orcid":false,"given":"Ben W","family":"Mol","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University, Monash Medical Centre , Clayton, Victoria, Australia"},{"name":"Aberdeen Centre for Women\u2019s Health Research, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen , Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8980-0909","authenticated-orcid":false,"given":"Wentao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University, Monash Medical Centre , Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9040-7829","authenticated-orcid":false,"given":"Juanzi","family":"Shi","sequence":"additional","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital , Xi'an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"2022080105593664100_deac113-B1","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/humrep\/del484","article-title":"Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial","volume":"22","author":"Baart","year":"2007","journal-title":"Hum Reprod"},{"key":"2022080105593664100_deac113-B2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.fertnstert.2015.07.1151","article-title":"Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles","volume":"104","author":"Baker","year":"2015","journal-title":"Fertil Steril"},{"key":"2022080105593664100_deac113-B3","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/humrep\/dex299","article-title":"High gonadotropin dosage does not affect euploidy and pregnancy rates in IVF PGS cycles with single embryo transfer","volume":"32","author":"Barash","year":"2017","journal-title":"Hum Reprod"},{"key":"2022080105593664100_deac113-B4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fendo.2020.00192","article-title":"What is the best regimen for ovarian stimulation of poor responders in ART\/IVF?","volume":"11","author":"Blumenfeld","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2022080105593664100_deac113-B5","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/humrep\/deq125","article-title":"Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles","volume":"25","author":"Bosch","year":"2010","journal-title":"Hum Reprod"},{"key":"2022080105593664100_deac113-B6","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2003.07.002","article-title":"Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome","volume":"80","author":"Bosch","year":"2003","journal-title":"Fertil Steril"},{"key":"2022080105593664100_deac113-B7","doi-asserted-by":"crossref","first-page":"E845","DOI":"10.1152\/ajpendo.00398.2004","article-title":"Effects of recombinant human follicle-stimulating hormone on embryo development in mice","volume":"288","author":"Edwards","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022080105593664100_deac113-B8","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0015-0282(00)00518-5","article-title":"Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer","volume":"73","author":"Gardner","year":"2000","journal-title":"Fertil Steril"},{"key":"2022080105593664100_deac113-B9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.fertnstert.2014.08.002","article-title":"Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement","volume":"102","author":"Harbin Consensus Conference Workshop Group","year":"2014","journal-title":"Fertil Steril"},{"key":"2022080105593664100_deac113-B10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0015-0282(00)01643-5","article-title":"A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-beta) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles","volume":"75","author":"Harrison","year":"2001","journal-title":"Fertil Steril"},{"key":"2022080105593664100_deac113-B11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1472-6483(10)60323-9","article-title":"Expected poor ovarian response in predicting cumulative pregnancy rates: a powerful tool","volume":"17","author":"Hendriks","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"2022080105593664100_deac113-B12","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/humrep\/deh655","article-title":"Oocyte number per live birth in IVF: were Steptoe and Edwards less wasteful?","volume":"20","author":"Inge","year":"2005","journal-title":"Hum Reprod"},{"key":"2022080105593664100_deac113-B13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/humrep\/deh663","article-title":"Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial","volume":"20","author":"Klinkert","year":"2005","journal-title":"Hum Reprod"},{"key":"2022080105593664100_deac113-B14","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.fertnstert.2004.09.039","article-title":"Development of a hamster superovulation program and adverse effects of gonadotropins on microfilament formation during oocyte development","volume":"83","author":"Lee","year":"2005","journal-title":"Fertil Steril"},{"key":"2022080105593664100_deac113-B15","first-page":"CD012693","article-title":"Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI)","volume":"2","author":"Lensen","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2022080105593664100_deac113-B16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.fertnstert.2019.11.023","article-title":"Natural cycle frozen-thawed embryo transfer in young women with regular menstrual cycles increases the live-birth rates compared with hormone replacement treatment: a retrospective cohort study","volume":"113","author":"Liu","year":"2020","journal-title":"Fertil Steril"},{"key":"2022080105593664100_deac113-B17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijgo.2008.08.012","article-title":"The influence of body mass index on in vitro fertilization outcome","volume":"104","author":"Orvieto","year":"2009","journal-title":"Int J Gynaecol"},{"key":"2022080105593664100_deac113-B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dmr037","article-title":"The poor responder in IVF: is the prognosis always poor?: a systematic review","volume":"18","author":"Oudendijk","year":"2012","journal-title":"Hum Reprod Update"},{"key":"2022080105593664100_deac113-B19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2018.04.039","article-title":"Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization\/intracytoplasmic sperm injection: a multicenter multinational analysis including \u223c15,000 women","volume":"110","author":"Polyzos","year":"2018","journal-title":"Fertil Steril"},{"key":"2022080105593664100_deac113-B20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1095\/biolreprod.104.032003","article-title":"Follicle-stimulating hormone affects metaphase I chromosome alignment and increases aneuploidy in mouse oocytes matured in vitro","volume":"72","author":"Roberts","year":"2005","journal-title":"Biol Reprod"},{"key":"2022080105593664100_deac113-B21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/humrep\/del445","article-title":"Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients","volume":"22","author":"Smitz","year":"2007","journal-title":"Hum Reprod"},{"key":"2022080105593664100_deac113-B22","doi-asserted-by":"crossref","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI","volume":"2020","author":"The ESHRE Guideline Group on ovarian stimulation","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2022080105593664100_deac113-B23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/GCO.0000000000000452","article-title":"What is new in the management of poor ovarian response in IVF?","volume":"30","author":"Vaiarelli","year":"2018","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2022080105593664100_deac113-B24","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/humrep\/dex321","article-title":"Individualized FSH dosing based on ovarian reserve testing in women starting IVF\/ICSI: a multicentre trial and cost-effectiveness analysis","volume":"32","author":"van Tilborg","year":"2017","journal-title":"Hum Reprod"},{"key":"2022080105593664100_deac113-B25","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1093\/humrep\/dex318","article-title":"Individualized versus standard FSH dosing in women starting IVF\/ICSI: an RCT. Part 1: The predicted poor responder","volume":"32","author":"van Tilborg","year":"2017","journal-title":"Hum Reprod"},{"key":"2022080105593664100_deac113-B26","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.fertnstert.2004.11.056","article-title":"An initial low response predicts poor outcome in in vitro fertilization\/intracytoplasmic sperm injection despite improved ovarian response in consecutive cycles","volume":"83","author":"Veleva","year":"2005","journal-title":"Fertil Steril"},{"key":"2022080105593664100_deac113-B27","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/humrep\/dey270","article-title":"Dosage of exogenous gonadotropins is not associated with blastocyst aneuploidy or live-birth rates in PGS cycles in Chinese women","volume":"33","author":"Wu","year":"2018","journal-title":"Hum Reprod"},{"key":"2022080105593664100_deac113-B28","first-page":"112","article-title":"A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial","volume":"32","author":"Youssef","year":"2017","journal-title":"Hum Reprod"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/8\/1806\/45197796\/deac113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/8\/1806\/45197796\/deac113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T02:01:10Z","timestamp":1659319270000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/37\/8\/1806\/6589877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,5,20]]},"published-print":{"date-parts":[[2022,7,30]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deac113","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2022,5,20]]}}}